ARCHIVES

Tarceva-Induced Rash Strongly Associated With Longer Survival, Sponsor Finds

This article is from The Cancer Letter archive.

Vol. 30 No. 7 | July 27, 2007

Download PDF Visit The Full Archive

Related Articles

In Brief: Susan O’Brien to move to UC Irvine Health

November 14, 2014

Litton Sells Clinical Labs, Planning to Join Recompetition For FCRF Contracts

July 12, 1985

FDA Approves Afinitor For Advanced Kidney Cancer

March 27, 2009

STAR Begins: Critics of Trial Call For Including A Placebo Arm

June 4, 1999

New Core Gant Guideline Proposals Drawn Up; Opposition Developing Among Center Directors

April 4, 1980

Study Section Members Seek NIH Use Of Normalization, Sliding Scale

April 16, 1982